DERM
Journey Medical Corp
6.10$
-2.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.6% | -13.4% | -2.1% | -1.8% | +25.3% | +5.9% | -4.5% | +5.0% | +11.0% | -3.2% | +7.5% | |
| – | +26.3% | -16.7% | -1.2% | -0.7% | +4.4% | +12.1% | -5.0% | +10.0% | +18.6% | -2.9% | +12.0% | |
| – | +10.9% | -12.3% | -0.6% | -6.1% | -9.6% | +3.8% | -3.7% | +22.9% | -3.4% | +13.0% | -5.8% | |
| – | +10.9% | -12.3% | -0.6% | -6.1% | -9.6% | +3.8% | -3.7% | +22.9% | -3.4% | +13.0% | -5.8% | |
| – | +90.5% | -35.6% | +6.8% | +2.0% | -4.1% | +76.2% | -13.2% | +15.0% | +65.6% | -16.1% | +45.0% | |
| – | -7.4% | +3.7% | -8.4% | +21.7% | +22.4% | -13.4% | +2.8% | -8.0% | -18.6% | -3.4% | -12.2% | |
| – | -3.9% | -4.0% | -4.2% | -4.4% | +78.6% | -3.3% | -3.5% | -3.6% | -3.7% | -4.1% | -3.7% | |
| – | +16.4% | -5.1% | +0.5% | -1.4% | +13.3% | +5.4% | -2.4% | -4.2% | +5.8% | -3.2% | +9.1% | |
| – | -13.7% | -7.0% | -12.3% | -2.4% | +5.5% | +14.3% | +0.6% | -1.9% | -5.7% | +1.0% | +21.0% | |
| – | +0.1% | -0.5% | -0.8% | -58.0% | -44.9% | +178.0% | +95.4% | +48.8% | -98.2% | +2,468.3% | +95.4% | |
| – | -45.0% | -13.4% | +4.9% | +5.0% | +4.6% | -10.3% | -11.5% | -9.4% | -23.4% | -2.0% | -7.2% | |
| – | – | +0.4% | +34.5% | +0.2% | +25.7% | -7.1% | -7.5% | -8.6% | +29.4% | -9.5% | -10.5% | |
| – | +17.1% | -36.4% | -12.8% | -3.3% | +83.7% | +7.3% | -10.7% | +34.6% | +23.0% | -3.2% | +4.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.1% | +2.2% | +1.2% | +2.7% | +7.9% | +2.1% | +3.0% | +7.2% | -1.8% | +11.5% | +0.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.